Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001839882-25-014522
Filing Date
2025-03-07
Accepted
2025-03-07 16:42:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8079
2 JOINT FILING AGREEMENT ex99-a.htm EX-99.(A) 3886
  Complete submission text file 0001839882-25-014522.txt   13858
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Subject) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89797 | Film No.: 25720743
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3300 EDINBOROUGH WAY SUITE 201 EDINA MN 55435
Business Address 3300 EDINBOROUGH WAY SUITE 201 EDINA MN 55435 952-831-6500
First Light Asset Management, LLC (Filed by) CIK: 0001600004 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G